Cargando…
Adult WHO grade II ependymomas: is Ki67 a sex-specific proliferation marker?
Ki67 is a marker for proliferation of a given cell population. Low expression of Ki67 may be associated with a favourable outcome. We investigate how the proliferation index correlates with the location, morphology and behaviour of WHO grade II ependymomas with a single-centre cohort study of adult...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382314/ https://www.ncbi.nlm.nih.gov/pubmed/34434542 http://dx.doi.org/10.1093/jscr/rjab333 |
_version_ | 1783741524020822016 |
---|---|
author | Baig Mirza, Asfand Lavrador, José Pedro Mancuso-Marcello, Marco Acharya, Shami Boardman, Timothy Martyn Bodi, Istvan Gullan, Richard Vergani, Francesco Bhangoo, Ranj Ashkan, Keyoumars |
author_facet | Baig Mirza, Asfand Lavrador, José Pedro Mancuso-Marcello, Marco Acharya, Shami Boardman, Timothy Martyn Bodi, Istvan Gullan, Richard Vergani, Francesco Bhangoo, Ranj Ashkan, Keyoumars |
author_sort | Baig Mirza, Asfand |
collection | PubMed |
description | Ki67 is a marker for proliferation of a given cell population. Low expression of Ki67 may be associated with a favourable outcome. We investigate how the proliferation index correlates with the location, morphology and behaviour of WHO grade II ependymomas with a single-centre cohort study of adult patients admitted for surgery of WHO grade II ependymomas between 2008 and 2018. Seventeen patients were included, seven had supratentorial and 10 had infratentorial tumours. Three patients died and eight had recurrent disease. Age, gender, location, extent of resection, chemotherapy, radiotherapy and histological markers were not associated with tumour progression. Both unadjusted and adjusted analysis confirmed a higher Ki67 index in male patients. Sensitivity analysis further supported the correlation between Ki67 and male gender. Ki67 may be sex specific but does not seem to correlate with survival and time to recurrence in this series. |
format | Online Article Text |
id | pubmed-8382314 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-83823142021-08-24 Adult WHO grade II ependymomas: is Ki67 a sex-specific proliferation marker? Baig Mirza, Asfand Lavrador, José Pedro Mancuso-Marcello, Marco Acharya, Shami Boardman, Timothy Martyn Bodi, Istvan Gullan, Richard Vergani, Francesco Bhangoo, Ranj Ashkan, Keyoumars J Surg Case Rep Case Series Ki67 is a marker for proliferation of a given cell population. Low expression of Ki67 may be associated with a favourable outcome. We investigate how the proliferation index correlates with the location, morphology and behaviour of WHO grade II ependymomas with a single-centre cohort study of adult patients admitted for surgery of WHO grade II ependymomas between 2008 and 2018. Seventeen patients were included, seven had supratentorial and 10 had infratentorial tumours. Three patients died and eight had recurrent disease. Age, gender, location, extent of resection, chemotherapy, radiotherapy and histological markers were not associated with tumour progression. Both unadjusted and adjusted analysis confirmed a higher Ki67 index in male patients. Sensitivity analysis further supported the correlation between Ki67 and male gender. Ki67 may be sex specific but does not seem to correlate with survival and time to recurrence in this series. Oxford University Press 2021-08-24 /pmc/articles/PMC8382314/ /pubmed/34434542 http://dx.doi.org/10.1093/jscr/rjab333 Text en Published by Oxford University Press and JSCR Publishing Ltd. © The Author(s) 2021. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Series Baig Mirza, Asfand Lavrador, José Pedro Mancuso-Marcello, Marco Acharya, Shami Boardman, Timothy Martyn Bodi, Istvan Gullan, Richard Vergani, Francesco Bhangoo, Ranj Ashkan, Keyoumars Adult WHO grade II ependymomas: is Ki67 a sex-specific proliferation marker? |
title | Adult WHO grade II ependymomas: is Ki67 a sex-specific proliferation marker? |
title_full | Adult WHO grade II ependymomas: is Ki67 a sex-specific proliferation marker? |
title_fullStr | Adult WHO grade II ependymomas: is Ki67 a sex-specific proliferation marker? |
title_full_unstemmed | Adult WHO grade II ependymomas: is Ki67 a sex-specific proliferation marker? |
title_short | Adult WHO grade II ependymomas: is Ki67 a sex-specific proliferation marker? |
title_sort | adult who grade ii ependymomas: is ki67 a sex-specific proliferation marker? |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382314/ https://www.ncbi.nlm.nih.gov/pubmed/34434542 http://dx.doi.org/10.1093/jscr/rjab333 |
work_keys_str_mv | AT baigmirzaasfand adultwhogradeiiependymomasiski67asexspecificproliferationmarker AT lavradorjosepedro adultwhogradeiiependymomasiski67asexspecificproliferationmarker AT mancusomarcellomarco adultwhogradeiiependymomasiski67asexspecificproliferationmarker AT acharyashami adultwhogradeiiependymomasiski67asexspecificproliferationmarker AT boardmantimothymartyn adultwhogradeiiependymomasiski67asexspecificproliferationmarker AT bodiistvan adultwhogradeiiependymomasiski67asexspecificproliferationmarker AT gullanrichard adultwhogradeiiependymomasiski67asexspecificproliferationmarker AT verganifrancesco adultwhogradeiiependymomasiski67asexspecificproliferationmarker AT bhangooranj adultwhogradeiiependymomasiski67asexspecificproliferationmarker AT ashkankeyoumars adultwhogradeiiependymomasiski67asexspecificproliferationmarker |